The C2238/αANP variant is a negative modulator of both viability and function of coronary artery smooth muscle cells.
about
Atrial natriuretic peptide in cardiovascular biology and disease (NPPA)Cardiac Natriuretic Peptides, Hypertension and Cardiovascular RiskC2238 ANP gene variant promotes increased platelet aggregation through the activation of Nox2 and the reduction of cAMP.C2238/αANP modulates apolipoprotein E through Egr-1/miR199a in vascular smooth muscle cells in vitro.The T2238C Human Atrial Natriuretic Peptide Molecular Variant and the Risk of Cardiovascular Diseases.T2238C Atrial Natriuretic Peptide Gene Variant and the Response to Antiplatelet Therapy in Stable Ischemic Heart Disease Patients.
P2860
The C2238/αANP variant is a negative modulator of both viability and function of coronary artery smooth muscle cells.
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The C2238/αANP variant is a ne ...... ry artery smooth muscle cells.
@ast
The C2238/αANP variant is a ne ...... ry artery smooth muscle cells.
@en
type
label
The C2238/αANP variant is a ne ...... ry artery smooth muscle cells.
@ast
The C2238/αANP variant is a ne ...... ry artery smooth muscle cells.
@en
prefLabel
The C2238/αANP variant is a ne ...... ry artery smooth muscle cells.
@ast
The C2238/αANP variant is a ne ...... ry artery smooth muscle cells.
@en
P2860
P50
P1433
P1476
The C2238/αANP variant is a ne ...... ry artery smooth muscle cells.
@en
P2093
Cristina Bozzao
Sara Di Castro
P2860
P304
P356
10.1371/JOURNAL.PONE.0113108
P407
P50
P577
2014-11-17T00:00:00Z